Cristi Barnett | executive |
Gilmore O’Neill | executive |
Baisong Mei | executive |
Erick Lucera | executive |
Joon Lee | analyst |
Samantha Lynn Semenkow | analyst |
Lut Ming Cheng | analyst |
Greg Harrison | analyst |
Caren Deardorf | executive |
Mani Foroohar | analyst |
Maxwell Skor | analyst |
Huidong Wang | analyst |
Dae Gon Ha | analyst |
Ry Forseth | analyst |
Philip Nadeau | analyst |
Jay Olson | analyst |
Yanan Zhu | analyst |
Luca Issi | analyst |
Timur Ivannikov | analyst |
Jack Allen | analyst |
Good morning, and welcome to Editas Medicine's Fourth Quarter and Full Year 2023 Conference Call. [Operator Instructions] Please be advised that this call is being recorded at the company's request.I would now like to turn the call over to Cristi Barnett, Corporate Communications and Investor Relations at Editas Medicine.
Thank you, Maria. Good morning, everyone, and welcome to our Fourth Quarter and Full Year 2023 Conference Call. Earlier this morning, we issued a press release providing our financial results and recent corporate updates.